logo
Plus   Neg
Share
Email

Regeneron Pharma: REGN3500 Meets Primary Endpoint In Phase 2 Study

Regeneron Pharmaceuticals, Inc. (REGN) and Sanofi (SNYNF,SNY) said the results from a Phase 2 proof-of-concept trial showed that the investigational antibody REGN3500 may provide an alternative targeted approach for patients suffering from asthma. In the trial, REGN3500 monotherapy significantly reduced loss of asthma control and improved lung function compared to placebo.

George Yancopoulos, President and Chief Scientific Officer at Regeneron, said: "We look forward to working with Sanofi to advance REGN3500 through our asthma clinical trial program, as well as continuing our ongoing trials in atopic dermatitis and chronic obstructive pulmonary disease."

REGN3500 was invented using Regeneron's VelocImmune technology, and is being developed jointly by Regeneron and Sanofi as part of a global agreement.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Walmart Inc. launched its first-ever car seat recycling event at nearly 4,000 stores across the country in partnership with waste management company TerraCycle. Customers who trade in used car seats at participating Walmart stores will receive a $30 Walmart gift card that can be used in store or online to buy items for their baby. Any brand of car seat is accepted through the program. Amazon Music launched a premium quality music service, Amazon Music HD, with more than 50 million songs in High Definition. The service also has millions of songs in Ultra High Definition. It is available for streaming in the U.S., U.K., Germany and Japan. Apple, Inc. is set to launch the much awaited Apple Arcade for mobile, desktop and the living room on September 19, 2019 in more than 150 countries. The world's first game subscription service can be accessed from an all-new tab on the App Store across iOS, macOS and tvOS. Apple Arcade will be available on the App Store on iOS 13. It will be available on iPadOS and tvOS 13 on September 30.
Follow RTT